Skip to contentS
Selectis Health, Inc.
S
GBCSSelectis Health, Inc. Q4 2022 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$9.46M$9.46Mderived−7.2% vs Q4 2021 Net Income-$2.19M-$2.19MderivedN/M vs Q4 2021 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Selectis Health, Inc. · CIK 727346 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$1,901,878N/M Operating Cash Flowderived$345,500−74.1% Free Cash Flowderived$453,908−65.3% Margins · derivedOperating margin-20.1%−8.7 pt vs Q4 2021
Net margin-23.2%−5.8 pt vs Q4 2021
ended Dec 31, 2022 · filed Jun 30, 2023 · 181 d after period end